Predictive value of elevated uric acid in Turkish patients undergoing primary angioplasty for ST elevation myocardial infarction

Acta Cardiologica Sinica

Volumn 30, Issue 2, 2014, Pages 119-127

  Akgul, Ozgur ^a   Uyarel, Huseyin ^b   Pusuroglu, Hamdi ^a   Gul, Mehmet ^a   Isiksacan, Nilgun ^c   Turen, Selahattin ^a   Erturk, Mehmet ^a   Surgit, Ozgur ^a   Cetin, Mustafa ^d   Bulut, Umit ^a   Baycan, Omer Faruk ^a   Uslu, Nevzat ^a  

^a Training and Research Hospital   (Turkey)

^b School of Medicine   (Turkey)

^c Training and Research Hospital   (Turkey)

^d Department of Cardiology Rize Education and Research Hospital ^*  (Turkey)

Author keywords

Primary angioplasty; ST elevation myocardial infarction; Uric acid

Indexed keywords

URIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TURKEY (REPUBLIC); URIC ACID BLOOD LEVEL;

EID: 84898419273     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Fox KA, Cokkinos DV, Deckers J, et al. The ENACT study: a pan-European survey of acute coronary syndromes. Eur Heart J 2000;21:1440-9. (Pubitemid 30636323)
2. Fox KA, Goodman SG, Anderson FA Jr, et al GRACE Investigators. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1414-24. (Pubitemid 36961831)
3. Kolansky DM. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care 2009;15:S36-41.
4. Bickel C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002;89:12-7. (Pubitemid 34066579)
5. Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006;37:1503-7. (Pubitemid 44305733)
6. Niskanen LK, Laaksonen DE, Nyyssönen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:1546-51. (Pubitemid 38970476)
7. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-Up Study. Am J Epidemiol 1995;141:637-44.
8. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999;131:7-13. (Pubitemid 29310011)
9. Lazzeri C, Valente S, Chiostri M, et al. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol 2010;138:206-9.
10. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-67.
11. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-83. (Pubitemid 43855050)
12. Schröder R, Dissmann R, Bruggemann T, et al. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 1994;24:384-91. (Pubitemid 24246537)
13. Schröder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 2004;110:506-10.
14. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987;76:142-54. (Pubitemid 17093202)
15. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967;20:457-64.
16. Kojima S, Sakamoto T, Ishihara M, et al. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 2005;96:489-95. (Pubitemid 41132762)
17. Lazzeri C, Valente S, Chiostri M, et al. Uric acid in the early risk stratification of ST-elevation myocardial infarction. Intern Emerg Med 2012;7:33-9.
18. Akpek M, Kaya MG, Uyarel H, et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis 2011;219:334-41.
19. Duran M, Ornek E, Murat SN, et al. High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome. Angiology 2012;63:472-5.
20. Kowalczyk J, Francuz P, Swoboda R, et al. Prognostic significance of hyperuricemia in patients with different types of renal dysfunction and acute myocardial infarction treated with percutaneous coronary intervention. Nephron Clin Pract 2010;116:c114-22.
21. Huczek Z, Kochman J, Filipiak KJ, et al. Mean platelet volume on admission predicts impaired reperfusion and longterm mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005;46:284-90. (Pubitemid 40966857)
22. Kaya MG, Uyarel H, Akpek M, et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012;109:486-91.
23. Ndrepepa G, Braun S, Haase HU, et al. Prognostic value of uric acid in patients with acute coronary syndromes. Am J Cardiol 2012;109:1260-5.
24. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003;108:1664-72. (Pubitemid 37243650)
25. Ruggiero C, Cherubini A, Ble A, et al. Uric acid and inflammatory markers. Eur Heart J 2006;27:1174-81.
26. Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 1996;174:288-91. (Pubitemid 26037726)
27. Kato M, Hisatome I, Tomikura Y, et al. Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol 2005;96:1576-8. (Pubitemid 41690182)
28. Erdogan D, Gullu H, Caliskan M, et al. Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 2005;59:1276-82. (Pubitemid 43904496)
29. Caymaz O. Chronic heart failure and uric acid. Türk J Cardiol 2006;9:110-4.
30. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics 1996;98:103-7. (Pubitemid 26226981)
31. Romano M, Buffoli F, Tomasi L, et al. The no-reflow phenomenon in acute myocardial infarction after primary angioplasty: incidence, predictive factors, and long-term outcomes. J Cardiovasc Med (Hagerstown) 2008;9:59-63. (Pubitemid 351339908)
32. Pohl U, Busse R. Endothelium-dependent modulation of vascular tone and platelet function. Eur Heart J 1990;11:35-42. (Pubitemid 20181248)
33. Parent R, Paré R, Lavallée M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am J Physiol 1992;262:10-6.
34. Farquharson CA, Butler R, Hill A, et al. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002;106:221-6. (Pubitemid 34761303)